Published in Cell on December 03, 2015
Persistent microbiome alterations modulate the rate of post-dieting weight regain. Nature (2016) 2.06
Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol (2016) 1.27
The microbiome and innate immunity. Nature (2016) 1.05
The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation. J Cell Biol (2016) 0.98
A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage. Nat Immunol (2016) 0.94
The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway. Cell Mol Immunol (2016) 0.91
Inflammasome Complexes: Emerging Mechanisms and Effector Functions. Cell (2016) 0.90
Accounting for reciprocal host-microbiome interactions in experimental science. Nature (2016) 0.90
Inflammatory networks underlying colorectal cancer. Nat Immunol (2016) 0.88
New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases. Clin Transl Immunology (2016) 0.87
Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol (2016) 0.86
Host-Specific Functional Significance of Caenorhabditis Gut Commensals. Front Microbiol (2016) 0.84
Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol (2016) 0.83
Inflammasomes and intestinal inflammation. Mucosal Immunol (2017) 0.81
Dysbiosis and the immune system. Nat Rev Immunol (2017) 0.79
Linking the Microbiota, Chronic Disease, and the Immune System. Trends Endocrinol Metab (2016) 0.79
NAIP-NLRC4 Inflammasomes Coordinate Intestinal Epithelial Cell Expulsion with Eicosanoid and IL-18 Release via Activation of Caspase-1 and -8. Immunity (2017) 0.78
The Immune Response to Prevotella Bacteria in Chronic Inflammatory Disease. Immunology (2017) 0.77
IL-33 regulates the IgA-microbiota axis to restrain IL-1α-dependent colitis and tumorigenesis. J Clin Invest (2016) 0.77
Metabolites: messengers between the microbiota and the immune system. Genes Dev (2016) 0.77
Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy. Br J Cancer (2016) 0.77
Inflammation: Maintaining the mucosal barrier in intestinal inflammation. Nat Rev Gastroenterol Hepatol (2015) 0.76
The Role of the Microbiota in Shaping Infectious Immunity. Trends Immunol (2016) 0.76
The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases. Front Immunol (2017) 0.76
When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD. Mediators Inflamm (2016) 0.76
Pyrin-only protein 2 limits inflammation but improves protection against bacteria. Nat Commun (2017) 0.76
Regulation of inflammation by microbiota interactions with the host. Nat Immunol (2017) 0.75
Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors. Cell Mol Life Sci (2016) 0.75
Dietary Protein and Amino Acid Supplementation in Inflammatory Bowel Disease Course: What Impact on the Colonic Mucosa? Nutrients (2017) 0.75
The Goldilocks Conundrum: NLR Inflammasome Modulation of Gastrointestinal Inflammation during Inflammatory Bowel Disease. Crit Rev Immunol (2016) 0.75
Regulation of the gut microbiome by inflammasomes. Free Radic Biol Med (2016) 0.75
Non-alcoholic fatty liver and the gut microbiota. Mol Metab (2016) 0.75
Proteome changes in the small intestinal mucosa of growing pigs with dietary supplementation of non-starch polysaccharide enzymes. Proteome Sci (2017) 0.75
Inflammasomes in Myeloid Cells: Warriors Within. Microbiol Spectr (2017) 0.75
Interleukin-18: The Bouncer at the Mucosal Bar. Cell (2015) 0.75
Intrinsic Defense Mechanisms of the Intestinal Epithelium. Cell Host Microbe (2016) 0.75
Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients. MBio (2016) 0.75
Research Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's Disease. Gastroenterol Res Pract (2016) 0.75
An Intestinal Inflammasome - The ILC3-Cytokine Tango. Trends Mol Med (2016) 0.75
Autonomous immunity in mucosal epithelial cells: fortifying the barrier against infection. Microbes Infect (2016) 0.75
Talking about cross-talk: the immune system and the microbiome. Genome Biol (2016) 0.75
Epithelial Cell Inflammasomes in Intestinal Immunity and Inflammation. Front Immunol (2017) 0.75
Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development. Front Immunol (2017) 0.75
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Curr Neurol Neurosci Rep (2017) 0.75
The path towards microbiome-based metabolite treatment. Nat Microbiol (2017) 0.75
A wide diversity of bacteria from the human gut produces and degrades biogenic amines. Microb Ecol Health Dis (2017) 0.75
Effects of β-Glucans Ingestion on Alveolar Bone Loss, Intestinal Morphology, Systemic Inflammatory Profile, and Pancreatic β-Cell Function in Rats with Periodontitis and Diabetes. Nutrients (2017) 0.75
The remedy within: will the microbiome fulfill its therapeutic promise? J Mol Med (Berl) (2017) 0.75
Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System. Cell Metab (2017) 0.75
Group III phospholipase A2 promotes colitis and colorectal cancer. Sci Rep (2017) 0.75
Microbiome-Metabolome Responses to a High-Grain Diet Associated with the Hind-Gut Health of Goats. Front Microbiol (2017) 0.75
Taurine does not affect the composition, diversity, or metabolism of human colonic microbiota simulated in a single-batch fermentation system. PLoS One (2017) 0.75
Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature (2014) 4.28
Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell (2014) 3.52
Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis. Cell (2014) 3.33
Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors. Cell (2015) 2.88
Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science (2014) 2.22
The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome. Cell (2016) 1.51
High-resolution sequencing and modeling identifies distinct dynamic RNA regulatory strategies. Cell (2014) 1.13
The microbiome and innate immunity. Nature (2016) 1.05
Nuclear Retention of mRNA in Mammalian Tissues. Cell Rep (2015) 1.01
Distinct Murine Mucosal Langerhans Cell Subsets Develop from Pre-dendritic Cells and Monocytes. Immunity (2015) 0.81
Making the case for chromatin profiling: a new tool to investigate the immune-regulatory landscape. Nat Rev Immunol (2015) 0.81
Dysbiosis and the immune system. Nat Rev Immunol (2017) 0.79
Sequential feedback induction stabilizes the phosphate starvation response in budding yeast. Cell Rep (2014) 0.78
Microbiome-Modulated Metabolites at the Interface of Host Immunity. J Immunol (2017) 0.77
Systematic Investigation of Transcription Factor Activity in the Context of Chromatin Using Massively Parallel Binding and Expression Assays. Mol Cell (2017) 0.77
HDAC3 Is a Master Regulator of mTEC Development. Cell Rep (2016) 0.76
Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation. J Exp Med (2017) 0.75
CD74 is a novel transcription regulator. Proc Natl Acad Sci U S A (2016) 0.75
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma. Cell Rep (2019) 0.75
NFIL-trating the Host Circadian Rhythm-Microbes Fine-Tune the Epithelial Clock. Cell Metab (2017) 0.75
Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science (2017) 0.75
Bystander IFN-γ activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment. Nat Cancer (2020) 0.75